One-year antibody persistence and safety of a 4-dose schedule of MenACWY-CRM in healthy infants from South Korea

por Lee, Hoan-Jong, Jo, Dae Sun, Kim, Yun-Kyung, Lee, Hyunju, Kim, Kyung-Hyo, Lee, Dokyung, Curina, Carlo, Costantini, Marco, Barbi, Silvia, Miao, Yan, Pellegrini, Michele
Publicado 2019

Results from a large post-marketing safety surveillance study in the Republic of Korea with a quadrivalent meningococcal CRM-conjugate vaccine in individuals aged 2 months–55 years...

por Yoo, Byung Wook, Jung, Hye Lim, Byeon, Yoon Seob, Han, Dong Ki, Jeong, Nak Yeong, Curina, Carlo, Moraschini, Luca, Kim, Sung Jin, Bhusal, Chiranjiwi, Pellegrini, Michele, Miao, Yan
Publicado 2019